Dr. Agarwal’s Healthcare IPO Subscription Status and Updates

Dr. Agarwal’s Healthcare IPO has seen a tepid response so far, with a subscription of only 0.11x by the start of Day 2, indicating limited investor interest.

The company is offering shares in a price range of Rs 382–402, with a minimum lot size of 35 shares.

This Rs 3,027.26 crore IPO includes a fresh issue worth Rs 300 crores (0.74 crore shares) and an offer for sale of Rs 2,727.26 crores (6.78 crore shares). Keep an eye on the latest updates for Dr. Agarwal’s Healthcare IPO subscription status as the day goes

Dr. Agarwal’s Healthcare IPO Subscription Status - Day 2 

As of Day 2, Dr. Agarwal’s Healthcare IPO has been subscribed 0.11x overall, indicating a slow response. The retail individual investor category saw a subscription of 0.17x, while non-institutional investors subscribed 0.08x. Meanwhile, qualified institutional buyers have yet to place any bids (0x).

Updated as of January 30, 2025, at 11:20 AM

Dr. Agarwal’s Healthcare IPO Subscription Status - Day 1 

Dr. Agarwal’s Healthcare Limited IPO has been subscribed 0.07x at the end of Day 1. The retail category saw a subscription of 0.12x, Non-Institutional Investors (NIIs) subscribed 0.06x, and Qualified Institutional Buyers (QIBs) have not yet shown interest in the IPO.

Company Overview of Dr. Agarwal’s Healthcare IPO 

Dr. Agarwal’s Healthcare offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. The company also sells optical products, contact lenses, accessories, and eye care-related pharmaceuticals.

In the financial year 2024, Dr. Agarwal’s Healthcare held a market share of approximately 25% of India’s total eye care services market. This strong position is backed by its proven clinical excellence, which has helped establish a strong brand in the country.

Among its listed and unlisted peers, Dr. Agarwal’s Healthcare operates the largest network of eye care facilities in India, with 737 doctors and 209 centers. The company’s 193 facilities are spread across 14 states and 4 union territories, with 16 additional facilities in nine African countries. Operating an asset-light model with leased facilities enables the company to scale rapidly with minimal upfront investment.

Dr. Agarwal’s Healthcare is led by Dr. Amar Agarwal, who brings over 35 years of clinical experience in the eye care industry. He has received numerous awards for his contributions to ophthalmology. The company also boasts an experienced management team and strong institutional backing, with major shareholders including Temasek Holdings, Claymore Investments, and TPG.

Financial Overview

The company’s revenue from operations has shown growth between FY 2022 and FY 2024. 

EBITDA  and EBITDA margin have grown consistently too, indicating efficiency in operations. Key ratios ROE and ROCE are healthy.  ROE fall is due to an increase in equity.

Dr. Agarwal’s Healthcare IPO Details

• IPO Date: January 29, 2025 to January 31, 2025

• Price Band: Rs 382 to Rs 402 per share

• Lot Size: 35 shares

• Total Issue Size: 7,53,04,970 shares (amounting to Rs 3,027.26 Cr)

• Fresh Issue: 74,62,686 shares (amounting to Rs 300 Cr)

• Offer For Sale: 678,42,284 shares of Rs 1 (amounting to Rs 2,727.26 Cr)

• Allotment Date: February 3, 2025

• Listing Date:  February 5, 2025

How to Apply for Dr. Agarwal’s Healthcare IPO

• Visit the Rupeezy app or Rupezy DOCK.

• Navigate to the IPO section on the Home Page

• Here, you can view all the IPOs with details such as market lot, minimum bid quantity, price range, and analysis.

• You can read the Red Herring Prospectus for the issue details.

• Click on Apply.

• Enter UPI ID for payment & place the bid.

• While placing the bid, enter the cutoff price or desired price in the range specified. Select quantity as per lot size. 

• Submit to complete the order.